FWK Holdings LLC et al v. Takeda Pharmaceutical Company Ltd. et al

Track this case

Case Number:

1:21-cv-11057

Court:

Massachusetts

Nature of Suit:

Anti-Trust

Multi Party Litigation:

Class Action

Judge:

Myong J. Joun

Firms

Companies

Sectors & Industries:

October 07, 2025
Premera Defends IBS Drug Antitrust Claims Against Takeda

Health insurers and self-insured employers represented by Premera Blue Cross urged a Massachusetts federal judge not to nix a series of state law antitrust claims from the broader certified class action accusing Takeda Pharmaceutical of paying Par Pharmaceuticals to delay generic competition to anticonstipation drug Amitiza.
September 19, 2025
IBS Drug Buyers Win Class Cert. In Takeda Antitrust Case

A Massachusetts federal judge on Friday certified buyer classes in litigation alleging Takeda Pharmaceutical broke antitrust law by cutting a pay-for-delay deal with Par Pharmaceuticals to keep a generic version of Takeda's anti-constipation drug Amitiza off the market for several years.
March 20, 2025
Judge Won't Let Meijer Appeal Takeda's Arbitration Mandate

A Massachusetts federal judge refused Thursday to let Meijer immediately appeal his order letting Takeda Pharmaceutical force the grocery chain into arbitration and out of its role as a representative of a proposed class of direct purchasers suing over delayed generics to a constipation drug.
March 04, 2025
Meijer Says 1st Circ. Must Resolve Takeda Arbitration Order

Grocery store chain Meijer on Tuesday urged a Massachusetts federal judge to allow it to immediately appeal his ruling granting Takeda Pharmaceutical's bid to arbitrate the grocer's antitrust claims over a constipation drug, arguing that the case presents several issues that the First Circuit needs to address.
January 27, 2025
Takeda Pushes Meijer Antitrust Suit Into Arbitration

Meijer is going to have to arbitrate its claims that Takeda Pharmaceutical broke antitrust law by cutting a pay-for-delay deal with Par Pharmaceuticals to keep a generic version of Takeda's anti-constipation drug Amitiza off the market for several years.
July 10, 2024
Meijer Says Takeda Can't Force Antitrust Suit Into Arbitration

Meijer argued before a Massachusetts federal court that Takeda waited far too long to try to force the supermarket chain to arbitrate its proposed class action accusing the Japanese pharmaceutical company of conspiring to delay a generic version of its anti-constipation drug Amitiza.
January 23, 2023
Court Consolidates Takeda Antitrust Suits Over IBS Drug

A Massachusetts federal judge on Monday consolidated a pair of proposed class actions alleging that Takeda Pharmaceutical broke antitrust law by cutting a pay-for-delay deal to keep a generic version of its anti-constipation drug Amitiza off the market for over six years.
June 28, 2021
Takeda Hit With Antitrust Suit Over IBS Drug Amitiza

Takeda Pharmaceutical broke antitrust law when it cut a pay-for-delay deal with Par Pharmaceuticals to keep a generic version of Takeda's anti-constipation drug Amitiza off the market for more than six years, according to a proposed class action in Massachusetts federal court.